24 Apr 2020DB Schenker COVID19 Response Conference.

Dr Chung, J. F.

Xylonix peer-reviewed publications and public presentations on topics of next-gen cancer immunotherapies, COVID19 endemic crisis & response, and on ageing immunity.  

24 Sep 2020 – Translational Oncology Summit

Publications

Chung, J. F. et al.

NO-dependent attenuation of TPA-induced immunoinflammatory skin changes in Balb/c mice by pindolol, heptaminol or ATRA, but not by verapamil.

Oncotarget (2016).

Chung, J. F., Lee, S. J. & Sood, A. K.

Immunological and pleiotropic effects of individual beta-blockers and their relevance in cancer therapies.

Expert opinion on investigational drugs (2016).

 

 
Chung, J. F., Lee, S. J. & Sood, A. K.

Immunological consequences of ageing microvascular hemodynamic changes in view of cancer development and treatment.

Oncotarget (2017).

Lee, S. J., Park, S. H., Chung, J. F., Choi, W. & Huh, H. K.

Homocysteine-induced peripheral microcirculation dysfunction in zebrafish and its attenuation by L-arginine.

Oncotarget (2017)

Chung, J. F., Her, Z., Kong, W. M. & Chen, Q.

Parthanatos-inducing zinc agent C010DS-Zn elicits anti-tumor immune responses involving T cells and macrophages in vivo.

Pharmacovigilance and Drug Safety (2021).

Chung, J. F.

Chemo 2.0: Programmed necrosis agents for broader and more effective cancer immunotherapy.

Annals of Biological Research (2021).

Chung, J. F.

Future oncology concerns from post-COVID19 macrophage abberations.

EC Pharmacology and Toxicology (2021).

Chung, J. F.

COVID19 Vaccine's Delta Paradox and Dangers of Further Viral Evolution.

EC Pharmacology and Toxicology (2021).

Chung, J. F.

Long COVID, Non-COVID19 Excess Deaths, and Post-Pandemic Cardiovascular Disease Risks: Mechanistic Links and Intervention Opportunities.

Medical Research Archives (2023).